Probing intermolecular backbone H-bonding in serine proteinase-protein inhibitor complexes

Chemistry and Biology

Volumn 6, Issue 7, 1999, Pages 419-427

  Lu, Wuyuan ^a,c   Randal, Michael ^b   Kossiakoff, Anthony ^b,c   Kent, Stephen B H ^a  

^a Gryphon Therapeutics   (United States)

^b GENENTECH INC   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Eglin c; Hydrogen bonding; Native chemical ligation; Protein backbone engineering; Solid phase peptide synthesis

Indexed keywords

EID: 0033168207     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(99)80060-X     Document Type: Article

References (42)

1. Kauzmann, W. (1959). Some factors in the interpretation of protein denaturation. Adv. Protein Chem. 14, 1-63.
2. Dill, K.A. (1990). Dominant forces in protein folding. Biochemistry 29, 7133-7155.
3. Honig, B. & Yang, A.S. (1995). Free energy balance in protein folding. Adv. Protein Chem. 46, 27-58.
4. Myers, J.K. & Pace, C.N. (1996). Hydrogen bonding stabilizes globular proteins. Biophys. J. 71, 2033-2039.
5. Fersht, A.R. (1987). The hydrogen bond in molecular recognition. Trends Biochem Sci 12, 301-304.
6. Connelly, P.R., Thomson, J.A., et al., (1994). Enthalpy of hydrogen bond formation in a protein-ligand binding reaction. Proc. Natl. Acad. Sci. USA 91, 1964-1968.
7. Pauling, L., Corey, R.B. & Branson, H.R. (1951). The structure of protein: Two hydrogen-bonded helical configurations of the polypeptide chain. Proc. Natl Acad. Sci. USA 37, 205-211.
8. Baker, E.N. & Hubbard, R.E. (1984). Hydrogen bonding in globular proteins. Prog. Biophys. Mol. Biol. 44, 97-179.
9. Stickle, D.F., Presta, L.G., Dill, K.A. & Rose, G.D. (1992). Hydrogen bonding in globular proteins. J. Mol. Biol. 226, 1143-1159.
10. Kent, S.B. (1988). Chemical synthesis of peptides and proteins. Annu. Rev. Biochem. 57, 957-989.
11. Muir, T.W. & Kent, S.B. (1993). The chemical synthesis of proteins. Curr. Opin. Biotechnol. 4, 420-427.
12. Mendel, D., Cornish, V.W. & Schultz, P.G. (1995). Site-directed mutagenesis with an expanded genetic code. Annu. Rev. Biophys. Biomol. Struct. 24, 435-462.
13. Koh, J.T., Cornish, V.W. & Schultz, P.G. (1997). An experimental approach to evaluating the role of backbone interactions in proteins using unnatural amino acid mutagenesis. Biochemistry 36, 11314-11322.
14. Dawson, P.E., Muir, T.W., Clark-Lewis, I. & Kent, S.B. (1994). Synthesis of proteins by native chemical ligation. Science 266, 776-779.
15. Lu, W., Qasim, M.A., Laskowski, M., Jr. & Kent, S.B.H. (1997). Probing intermolecular main chain hydrogen bonding in serine proteinaseprotein inhibitor complexes: Chemical synthesis of backbone-engineered turkey ovomucoid third domain. Biochemistry 36, 673-679.
16. Frigerio, F., et al., & Bolognesi, M. (1992). Crystal and molecular structure of the bovine alpha-chymotrypsin-eglin c complex at 2.0 Å resolution. J. Mol. Biol. 225, 107-123.
17. Bode, W., Papamokos, E. & Musil, D. (1987). The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Eur. J. Biochem. 166, 673-692.
18. McPhalen, C.A. & James, M.N. (1988). Structural comparison of two serine proteinase-protein inhibitor complexes: Eglin-c-subtilisin Carlsberg and Cl-2-subtilisin Novo. Biochemistry 27, 6582-6598.
19. Heinz, D.W., Priestle, J.P., Rahuel, J., Wilson, K.S. & Grutter, M.G. (1991). Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes. J. Mol. Biol. 217, 353-371.
20. Gros, P., Teplyakov, A.V. & Hol, W.G. (1992). Effects of eglin-c binding to thermitase: Three-dimensional structure comparison of native thermitase and thermitase eglin-c complexes. Proteins 12, 63-74.
21. Laskowski, M., Jr. & Kato, I. (1980). Protein inhibitors of proteinases. Annu. Rev. Biochem. 49, 593-626.
22. Bode, W. & Huber, R. (1992). Natural protein proteinase inhibitors and their interaction with proteinases. Eur. J. Biochem. 204, 433-451.
23. Schechter, I. & Berger, A. (1967). On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27, 157-162.
24. Dodt, J., Seemuller, U. & Fritz, H. (1987). Influence of chain shortening on the inhibitor properties of hirudin and eglin c. Biol. Chem. Hoppe. Seyler. 368, 1447-1453.
25. Okada, Y., Tsuboi, S., Tsuda, Y., Nagamatsu, Y. & Yamamoto, J. (1990). Synthesis of a trihexacontapeptide corresponding to the sequence 8-70 of eglin c and studies on the relationship between the structure and the inhibitory activity against human leukocyte elastase, cathepsin G and alpha-chymotrypsin. FEBS Lett. 272, 113-116.
26. Read, R.J. & James, M.N.G. (1986). Introduction to the protein inhibitors. In Proteinase Inhibitors. (Barrett, A.J. & Salvesen, G., eds) pp. 301-336, Elsevier, Amsterdam.
27. Qasim, M.A., Ganz, P.J., Saunders, C.W., Bateman, K.S., James, M.N. & Laskowski, M., Jr. (1997). Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases. Biochemistry 36, 1598-1607.
28. Heinz, D.W., Hyberts, S.G., Peng, J.W., Priestle, J.P., Wagner, G. & Grutter, M.G. (1992). Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: Functional and structural investigation. Biochemistry 31, 8755-8766.
29. Bode, W., Meyer E., Jr. & Powers, J. C. (1989). Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity and mechanism-based inhibitors. Biochemistry 28, 1951-1963.
30. Groeger, C., Wenzel, H.R. & Tschesche, H. (1994). BPTI backbone variants and implications for inhibitory activity. Int. J. Pept. Protein. Res. 44, 166-172.
31. Mitchell, A.R., Kent, S.B.H., Engelhard, M. & Merrifield, R.B. (1978). A new synthetic route to tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin, an improved support for solid-phase peptide synthesis. J. Org. Chem. 43, 2845-2852.
32. Ryan, D.S. & Feeney, R.E. (1975). The interaction of inhibitors of proteolytic enzymes with 3-methylhistidine-57-chymotrypsin. J. Biol. Chem. 250, 843-847.
33. Green, N.M. & Work, E. (1953). Pancreatic trypsin inhibitor: 2. Reaction with trypsin. Biochem. J. 54, 347-352.
34. Empie, M.W. & Laskowski, M., Jr. (1982). Thermodynamics and kinetics of single residue replacements in avian ovomucoid third domains: Effect on inhibitor interactions with serine proteinases. Biochemistry 21, 2274-2284.
35. Canne, L.E., Walker, S.M. & Kent, S.B.H. (1995). A general method for the synthesis of thioester resin linkers for use in the solid phase synthesis of peptide-alpha-thioacids. Tetrahedron Lett. 36, 1217-1220.
36. Schnölzer, M., Alewood, P., Jones, A., Alewood, D. & Kent, S. B. (1992). In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int. J. Pept. Prot. Res. 40, 180-93.
37. Dawson, P.E., Churchill, M.J., Ghadiri, M.R. & Kent, S.B.H. (1997). Modulation of reactivity in native chemical ligation through the use of thiol additives. J. Am. Chem. Soc. 119, 4325-4329.
38. Lu, W., Qasim, M.A. & Kent, S.B.H. (1996). Comparative total syntheses of turkey ovomucoid third domain by both stepwise solid phase peptide synthesis and native chemical ligation. J. Am. Chem. Soc. 118, 8518-8523.
39. Kabsch, W. (1988). Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector. J. Appl. Crystallogr. 21, 1916-1934.
40. Navaza, J. (1994). AMORE - An automated package for molecular replacement. Acta. Crystallogr. D 50, 157-163.
41. Bernstein, F.C., et al.,. & Tasumi, M. (1977). The Protein Data Bank: A computer-based archival file for macromolecular structures. J. Mol. Biol. 112, 535-542.
42. Brünger, A.T. (1992) X-PLOR: A System for X-ray Crystallography and NMR. Yale University Press, New Haven CT, USA.